Los puntos clave no están disponibles para este artículo en este momento.
This study assesses mean emissions and costs and estimated total yearly emissions and costs for US-branded inhalers prescribed to Medicare Part D and Medicaid beneficiaries.
Tirumalasetty et al. (Thu,) studied this question.